Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

• Main Authors: Thongprasert S., Duffield E., Saijo N., Wu Y.-L., Yang J.C.-H., Chu D.-T., Liao M., Chen Y.-M., Kuo H.-P., Negoro S., Lam K.C., Armour A., Magill P., Fukuoka M.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-80054882063&partnerID=40&md5=a3b134d1b53530e6aaf637e86637e5cf; http://www.ncbi.nlm.nih.gov/pubmed/22011650; http://cmuir.cmu.ac.th/handle/6653943832/2978
• 機構: Chiang Mai University

Introduction: Evaluation of health-related quality-of-life (HRQoL) and symptom improvement were preplanned secondary objectives for the overall population and posthoc analyses for epidermal growth factor receptor (EGFR) mutation-positive/negative subgroups in IPASS. Methods: HRQoL was assessed using...